These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Direct plasma radioimmunoassay for rat amylin-(1-37): concentrations with acquired and genetic obesity. Pieber TR; Roitelman J; Lee Y; Luskey KL; Stein DT Am J Physiol; 1994 Jul; 267(1 Pt 1):E156-64. PubMed ID: 8048505 [TBL] [Abstract][Full Text] [Related]
23. Amylin and amylin-amide lack an acute effect on blood glucose and insulin. Ghatei MA; Datta HK; Zaidi M; Bretherton-Watt D; Wimalawansa SJ; MacIntyre I; Bloom SR J Endocrinol; 1990 Feb; 124(2):R9-11. PubMed ID: 2179452 [TBL] [Abstract][Full Text] [Related]
24. Different influence of CGRP (8-37), an amylin and CGRP antagonist, on the anorectic effects of cholecystokinin and bombesin in diabetic and normal rats. Lutz TA; Pieber TR; Walzer B; Del Prete E; Scharrer E Peptides; 1997; 18(5):643-9. PubMed ID: 9213356 [TBL] [Abstract][Full Text] [Related]
25. Effects of exogenous somatostatin and insulin on islet amyloid polypeptide (amylin) release from perfused rat pancreas. Inoue K; Hisatomi A; Umeda F; Nawata H Horm Metab Res; 1992 Jun; 24(6):251-3. PubMed ID: 1353050 [TBL] [Abstract][Full Text] [Related]
26. β₂-adrenoceptor and insulin receptor expression in the skeletal muscle of streptozotocin induced diabetic rats: antagonism by vitamin D₃ and curcumin. Xavier S; Sadanandan J; George N; Paulose CS Eur J Pharmacol; 2012 Jul; 687(1-3):14-20. PubMed ID: 22579915 [TBL] [Abstract][Full Text] [Related]
27. Deficiency of total and nonglycosylated amylin in plasma characterizes subjects with impaired glucose tolerance and type 2 diabetes. Mäkimattila S; Fineman MS; Yki-Järvinen H J Clin Endocrinol Metab; 2000 Aug; 85(8):2822-7. PubMed ID: 10946889 [TBL] [Abstract][Full Text] [Related]
28. Curcumin pretreatment mediates antidiabetogenesis via functional regulation of adrenergic receptor subtypes in the pancreas of multiple low-dose streptozotocin-induced diabetic rats. Naijil G; Anju TR; Jayanarayanan S; Paulose CS Nutr Res; 2015 Sep; 35(9):823-33. PubMed ID: 26255758 [TBL] [Abstract][Full Text] [Related]
29. Rat amylin-(8-37) enhances insulin action and alters lipid metabolism in normal and insulin-resistant rats. Hettiarachchi M; Chalkley S; Furler SM; Choong YS; Heller M; Cooper GJ; Kraegen EW Am J Physiol; 1997 Nov; 273(5):E859-67. PubMed ID: 9374670 [TBL] [Abstract][Full Text] [Related]
30. Impaired phasic insulin and amylin secretion in diabetic rats. Leahy JL; Fineman MS Am J Physiol; 1998 Sep; 275(3):E457-62. PubMed ID: 9725812 [TBL] [Abstract][Full Text] [Related]
32. Evidence that amylin stimulates lipolysis in vivo: a possible mediator of induced insulin resistance. Ye JM; Lim-Fraser M; Cooney GJ; Cooper GJ; Iglesias MA; Watson DG; Choong B; Kraegen EW Am J Physiol Endocrinol Metab; 2001 Apr; 280(4):E562-9. PubMed ID: 11254462 [TBL] [Abstract][Full Text] [Related]
33. Plasma amylin and insulin concentrations in normoglycemic and hyperglycemic cats. Lutz TA; Rand JS Can Vet J; 1996 Jan; 37(1):27-34. PubMed ID: 8746416 [TBL] [Abstract][Full Text] [Related]
34. Food deprivation increases alpha(2)-adrenoceptor-mediated modulation of jejunal epithelial transport in young and adult rats. Lucas-Teixeira V; Vieira-Coelho MA; Serrão MP; Soares-da-Silva P J Nutr; 2000 Oct; 130(10):2461-6. PubMed ID: 11015473 [TBL] [Abstract][Full Text] [Related]
35. Increased secretion and expression of amylin in spontaneously diabetic Goto-Kakizaki rats treated with rhGLP-1 (7-36). Weng HB; Gu Q; Liu M; Cheng NN; Li D; Gao X Acta Pharmacol Sin; 2008 May; 29(5):573-9. PubMed ID: 18430365 [TBL] [Abstract][Full Text] [Related]
36. In vivo insulin resistance induced by amylin primarily through inhibition of insulin-stimulated glycogen synthesis in skeletal muscle. Frontoni S; Choi SB; Banduch D; Rossetti L Diabetes; 1991 May; 40(5):568-73. PubMed ID: 2022302 [TBL] [Abstract][Full Text] [Related]
37. [Experimental study of amylin-induced functional damage to rat pancreatic islet cells in vitro]. Zhou L; Xue YM Di Yi Jun Yi Da Xue Xue Bao; 2003 Sep; 23(9):922-4. PubMed ID: 13129721 [TBL] [Abstract][Full Text] [Related]
38. Release of amylin from perfused rat pancreas in response to glucose, arginine, beta-hydroxybutyrate, and gliclazide. Inoue K; Hisatomi A; Umeda F; Nawata H Diabetes; 1991 Aug; 40(8):1005-9. PubMed ID: 1860552 [TBL] [Abstract][Full Text] [Related]
39. Role of amylin in insulin secretion and action in humans: antagonist studies across the spectrum of insulin sensitivity. Mather KJ; Paradisi G; Leaming R; Hook G; Steinberg HO; Fineberg N; Hanley R; Baron AD Diabetes Metab Res Rev; 2002; 18(2):118-26. PubMed ID: 11994903 [TBL] [Abstract][Full Text] [Related]
40. Normalization of insulin secretion by a selective alpha 2-adrenoceptor antagonist restores GLUT-4 glucose transporter expression in adipose tissue of type II diabetic rats. Angel I; Burcelin R; Prouteau M; Girard J; Langer SZ Endocrinology; 1996 May; 137(5):2022-7. PubMed ID: 8612543 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]